Clinical Trial Update: Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation [Phase 3]

View source ↗

Summary

Phase 3 trial comparing sotorasib plus panitumumab against investigator's choice in colorectal cancer with KRAS p.G12C mutation; the study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• LUMAKRAS (sotorasib)
• Vectibix (panitumumab)

Snippet

Sponsor: Amgen | Conditions: Colorectal Cancer (CRC) | Phase 3 | Status: ACTIVE_NOT_RECRUITING